<DOC>
	<DOCNO>NCT00214994</DOCNO>
	<brief_summary>A 12-Month , Open-Label , Flexible-Dosage Study Evaluate Safety Efficacy GABITRIL Treatment Adults Generalized Anxiety Disorder .</brief_summary>
	<brief_title>Study Evaluate Safety Efficacy GABITRIL Treatment Adults With Generalized Anxiety Disorder .</brief_title>
	<detailed_description />
	<mesh_term>Disease</mesh_term>
	<mesh_term>Anxiety Disorders</mesh_term>
	<mesh_term>Tiagabine</mesh_term>
	<criteria>Subjects complete 10 week doubleblind treatment subsequent taper period 1 3 previous doubleblind study ( study C6671/3030/AX/US , C6671/3031/AX/US , C6671/3032/AX/US ) .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>64 Years</maximum_age>
	<verification_date>May 2014</verification_date>
</DOC>